BIOVOX GmbH

Provides medical- and pharma-grade bioplastics for future-proof packaging and drug delivery devices, based on renewable resources and free from critical substances such as PFAS or BPA, offering thermoplastic polymers with up to 85% lower carbon footprint compared to fossil-based PVC/PET/PP films and injection molding grades like ABS, PP or PC. Based in Darmstadt, Germany, the company develops and produces VDI 2017 medical-grade bioplastics under an ISO 13485 quality management system, with all products pretested for biological safety according to ISO 10993.